Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-15-034702
Filing Date
2015-06-01
Accepted
2015-06-01 12:30:16
Documents
1
Period of Report
2015-05-21

Document Format Files

Seq Description Document Type Size
1 form4a74662_20150601122857-.html 4/A  
1 form4a74662_20150601122857-.xml 4/A 3418
  Complete submission text file 0001144204-15-034702.txt   4902
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O CARDINAL HEALTH INC 7000 CARDINAL PLACE DUBLIN OH 43235
Business Address
FORD BRENDAN A (Reporting) CIK: 0001236444 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35076 | Film No.: 15902251